EV/EBITDA
83.67
+2.98+3.69%
61 min ago
Summary
- As of March 12, 2025, GYRE EV/EBITDA is 83.67, with a rise of +2.98 (+3.69%) during the most recent trading day.
- Over the past year, GYRE EV/EBITDA has increased by +11.17 (+15.41%).
- GYRE EV/EBITDA is now -30.59% below its all-time high of 120.54.
Performance
GYRE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
GYRE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +3.7% | +3.7% | +3.6% |
| 1 m1 month | +5.4% | +5.4% | +5.3% |
| 3 m3 months | +17.2% | +17.2% | +16.9% |
| 6 m6 months | +43.9% | -15.4% | -15.4% |
| ytdytd | -3.6% | -3.6% | -3.5% |
| 1 y1 year | +15.4% | -33.0% | -33.9% |
| 5 y5 years | - | - | -78.8% |
GYRE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -8.2% | 73.85 | +13.3% | |
| 3 m | 3-month | 94.29 | -11.3% | 68.76 | +21.7% |
| 6 m | 6-month | 120.54 | -30.6% | 46.83 | +78.7% |
| 1 y | 1-year | 120.54 | -30.6% | 35.24 | +137.4% |
| 3 y | 3-year | 120.54 | -30.6% | 35.24 | +137.4% |
| 5 y | 5-year | 120.54 | -30.6% | 35.24 | +137.4% |
| alltime | all time | 120.54 | -30.6% | 35.24 | +137.4% |
Gyre Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 83.67(-3.6%) |
| Date | Value |
|---|---|
| 2024 | 86.80(-8.8%) |
| 2023 | 95.18 |
FAQ
- What is Gyre Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Gyre Therapeutics?
- What is GYRE EV/EBITDA year-to-date change?
- What is Gyre Therapeutics EV/EBITDA year-on-year change?
What is Gyre Therapeutics EV/EBITDA?
The current EV/EBITDA of GYRE is 83.67
What is the all time high EV/EBITDA for Gyre Therapeutics?
Gyre Therapeutics all-time high EV/EBITDA is 120.54
What is GYRE EV/EBITDA year-to-date change?
Gyre Therapeutics EV/EBITDA has changed by -3.13 (-3.61%) since the beginning of the year
What is Gyre Therapeutics EV/EBITDA year-on-year change?
Over the past year, GYRE EV/EBITDA has changed by +11.17 (+15.41%)